118895290	118895290	CD	B-NP	O
|	|	NNP	I-NP	O
SHGMC	SHGMC	NNP	I-NP	O
|	|	VBD	B-VP	O
14982405	14982405	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5894392	5894392	CD	B-NP	O
|	|	CC	I-NP	O
10/16/2004	10/16/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
R/O	R/O	NNP	I-NP	I-protein
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	I-protein
INFARCTION	INFARCTION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/16/2004	10/16/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/3/2004	4/3/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
BOYD	BOYD	NNP	B-NP	O
ENOCH	ENOCH	NNP	I-NP	O
GROTELUESCHEN	GROTELUESCHEN	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Dizziness	Dizziness	NN	B-NP	O
,	,	,	O	O
blurred	blur	VBD	B-VP	O
vision	vision	NN	B-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
OTHER	OTHER	NNP	B-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
glaucoma	glaucoma	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
56-year-old	56-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
weakness	weakness	NN	B-NP	O
and	and	CC	I-NP	O
blurry	blurry	NN	I-NP	O
vision	vision	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
at	at	IN	B-PP	O
Doyle	Doyle	NNP	B-NP	O
Health	Health	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Services	Service	NNPS	I-NP	O
7/20/04	7/20/04	CD	I-NP	O
through	through	IN	B-PP	O
10/17/04	10/17/04	CD	B-NP	O
with	with	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	B-protein
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
3	3	CD	B-NP	O
+	+	SYM	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
BNP	BNP	NN	I-NP	B-protein
of	of	IN	B-PP	O
1374	1374	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
echo	echo	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
and	and	CC	O	O
lost	lose	VBN	B-VP	O
10	10	CD	B-NP	O
kg	kg	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
CHF	CHF	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
recently	recently	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
recent	recent	JJ	I-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
Toprol	Toprol	NNP	I-NP	O
XL	XL	NN	I-NP	O
and	and	CC	I-NP	O
amlodipine	amlodipine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
weakness	weakness	NN	B-NP	O
and	and	CC	O	O
blurred	blur	VBD	B-VP	O
vision	vision	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
work	work	NN	B-NP	O
helping	help	VBG	B-VP	O
set	set	VB	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
party	party	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
became	become	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
week	week	NN	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
vision	vision	NN	I-NP	O
blurred	blur	VBD	B-VP	O
and	and	CC	O	O
this	this	DT	B-NP	O
resolved	resolve	VBN	B-VP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
sat	sit	VBD	B-VP	O
down	down	RP	B-PRT	O
to	to	TO	B-VP	O
rest	rest	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reports	report	VBZ	B-VP	O
having	have	VBG	I-VP	O
had	have	VBD	I-VP	O
one	one	CD	B-NP	O
similar	similar	JJ	I-NP	O
episode	episode	NN	I-NP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
seek	seek	VB	I-VP	O
medical	medical	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
palpitations	palpitation	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
days	day	NNS	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
episode	episode	NN	I-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
good	good	JJ	B-NP	O
appetite	appetite	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
dysuria	dysuria	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
vitals	vital	NNS	I-NP	O
were	be	VBD	B-VP	O
temperature	temperature	NN	B-NP	O
97.1	97.1	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
70	70	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
147/68	147/68	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
.	.	.	O	O

An	An	DT	B-NP	O
EKG	EKG	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
ST	ST	JJ	B-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
2.1	2.1	CD	B-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
was	be	VBD	B-VP	O
307	307	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Diabetes	Diabetes	NNP	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
cognitive	cognitive	JJ	B-NP	O
deficits	deficit	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
glaucoma	glaucoma	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
ADMISSION	ADMISSION	NN	B-NP	O
:	:	:	O	O
Amlodipine	Amlodipine	NN	B-NP	O
7.5	7.5	CD	B-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Timoptic	Timoptic	NNP	B-NP	O
0.5	0.5	CD	I-NP	O
one	one	CD	I-NP	O
drop	drop	NN	I-NP	O
OU	OU	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
XL	XL	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
atorvastatin	atorvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
mother	mother	NN	I-NP	O
and	and	CC	O	O
works	work	VBZ	B-VP	O
at	at	IN	B-PP	O
Ondo	Ondo	NNP	B-NP	O
Carmi	Carmi	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Cafeteria	Cafeteria	NNP	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
vitals	vital	NNS	B-NP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pulsations	pulsation	NNS	I-NP	O
were	be	VBD	B-VP	O
visible	visible	JJ	B-ADJP	O
at	at	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-ADJP	O
with	with	IN	B-PP	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
S4	S4	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
had	have	VBD	B-VP	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Scattered	Scattered	JJ	B-NP	O
excoriations	excoriation	NNS	I-NP	O
with	with	IN	B-PP	O
quite	quite	RB	B-NP	O
long	long	JJ	I-NP	O
nails	nail	NNS	I-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	O
AT	AT	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
5.3	5.3	NN	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
307	307	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.1	2.1	CD	B-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
7	7	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
42	42	CD	B-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
118	118	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
62	62	CD	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
T-wave	T-wave	NN	B-NP	O
inversions	inversion	NNS	I-NP	O
with	with	IN	B-PP	O
ST	ST	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
I	I	PRP	B-NP	O
,	,	,	O	O
II	II	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
V1	V1	NN	B-NP	B-protein
through	through	IN	B-PP	O
V5	V5	NN	B-NP	B-protein
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
stable	stable	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
any	any	DT	B-NP	O
time	time	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
concern	concern	NN	B-NP	O
over	over	IN	B-PP	O
possible	possible	JJ	B-NP	O
hypotension	hypotension	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
weakness	weakness	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
day	day	NN	I-NP	O
at	at	IN	B-PP	O
slightly	slightly	RB	B-NP	O
diminished	diminish	VBN	I-NP	O
doses	dose	NNS	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
improved	improve	VBD	B-VP	O
and	and	CC	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
poorly	poorly	RB	I-ADJP	O
controlled	control	VBN	I-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
present	present	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
A1c	A1c	NN	I-NP	O
measured	measure	VBN	B-VP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
11.4	11.4	CD	B-NP	O
indicating	indicate	VBG	B-VP	O
an	an	DT	B-NP	O
average	average	JJ	I-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
300	300	CD	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
in-house	in-house	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
receive	receive	VB	I-VP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
glipizide	glipizide	NN	B-NP	O
XL	XL	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
regular	regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
on	on	IN	B-PP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
prior	prior	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	O
use	use	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
consideration	consideration	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
risks	risk	NNS	I-NP	O
and	and	CC	I-NP	O
benefits	benefit	NNS	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
oral	oral	JJ	I-NP	O
agents	agent	NNS	I-NP	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
A1c	A1c	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
insulin	insulin	NN	B-NP	O
therapy	therapy	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
adequate	adequate	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

Various	Various	JJ	B-NP	O
concern	concern	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
successfully	successfully	RB	I-VP	O
manage	manage	VB	I-VP	O
insulin	insulin	NN	B-NP	O
therapy	therapy	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
so	so	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
simply	simply	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
selected	select	VBN	I-VP	O
.	.	.	O	O

To	To	TO	B-VP	O
begin	begin	VB	I-VP	O
with	with	IN	B-PRT	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
standing	standing	NN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	I-NP	O
6	6	CD	I-NP	O
units	unit	NNS	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
prefilled	prefilled	JJ	I-NP	O
disposable	disposable	JJ	I-NP	O
insulin	insulin	NN	I-NP	O
pen	pen	NN	I-NP	O
that	that	WDT	B-NP	O
will	will	MD	B-VP	O
involve	involve	VB	I-VP	O
no	no	DT	B-NP	O
need	need	NN	I-NP	O
to	to	TO	B-VP	O
draw	draw	VB	I-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
medication	medication	NN	I-NP	O
himself	himself	PRP	B-NP	O
,	,	,	O	O
but	but	CC	O	O
simply	simply	RB	B-ADVP	O
to	to	TO	B-VP	O
select	select	VB	I-VP	O
the	the	DT	B-NP	O
correct	correct	JJ	I-NP	O
dose	dose	NN	I-NP	O
and	and	CC	O	O
give	give	VB	B-VP	O
the	the	DT	B-NP	O
injection	injection	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
blurred	blurred	JJ	B-NP	O
vision	vision	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
recur	recur	VB	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
possible	possible	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
accounted	account	VBD	B-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
ophthalmologic	ophthalmologic	JJ	I-NP	O
exam	exam	NN	I-NP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
that	that	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
problems	problem	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
neurologic	neurologic	JJ	I-NP	O
or	or	CC	I-NP	O
visual	visual	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Fluid	Fluid	NN	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nutrition	nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
hyperkalemic	hyperkalemic	JJ	I-ADJP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
5.3	5.3	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
resolved	resolve	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Kayexalate	Kayexalate	NNP	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
on	on	IN	B-PP	O
6/19/04	6/19/04	CD	B-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
receive	receive	VB	I-VP	O
close	close	JJ	B-NP	O
followup	followup	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
visiting	visit	VBG	I-VP	O
nurses	nurse	NNS	B-NP	O
'	'	POS	B-NP	O
visits	visit	NNS	I-NP	O
including	include	VBG	B-PP	O
two	two	CD	B-NP	O
visits	visit	NNS	I-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
assist	assist	VB	I-VP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	O
management	management	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Clifford	Clifford	NNP	I-NP	O
Evanko	Evanko	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
on	on	IN	B-PP	O
5/6/04	5/6/04	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Timoptic	Timoptic	NNP	B-NP	O
0.5	0.5	CD	B-NP	O
%	%	NN	I-NP	O
one	one	CD	B-NP	O
drop	drop	NN	I-NP	O
OU	OU	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
XL	XL	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
atorvastatin	atorvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
6	6	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	I-ADVP	O
before	before	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-4544386	4-4544386	CD	B-NP	O
ISSten	ISSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Lane	Lane	NNP	B-NP	O
Strzyzewski	Strzyzewski	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
ECKLES	ECKLES	NNP	B-NP	O
,	,	,	O	O
TRUMAN	TRUMAN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FEGER	FEGER	NNP	B-NP	O
,	,	,	O	O
OMAR	OMAR	NNP	B-NP	O
LYLE	LYLE	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
4088169	4088169	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/5/04	1/5/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/11/04	10/11/04	CD	B-NP	O

